Development of an electronic device for subcutaneous injection of interferon beta-1a in patients with relapsing multiple sclerosis

被引:0
|
作者
Mikol, D. [1 ]
Verdun, E. [2 ,3 ]
Exell, S. [2 ,3 ]
Devonshire, V. [4 ]
机构
[1] EMD Serono, Rockland, MA USA
[2] Merck Serono SA, Geneva, Switzerland
[3] Merck KGaA, Darmstadt, Germany
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源
MULTIPLE SCLEROSIS | 2010年 / 16卷 / 10期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1282 / 1282
页数:1
相关论文
共 50 条
  • [21] Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
    Rudick, RA
    Goodkin, DE
    Jacobs, LD
    Cookfair, DL
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Granger, CV
    Simon, JH
    Alam, JJ
    Simonian, NA
    Campion, MK
    Bartoszak, DM
    Bourdette, DN
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Priore, RL
    Pullicino, PM
    Scherokman, BJ
    WeistockGuttman, B
    Whitham, RH
    NEUROLOGY, 1997, 49 (02) : 358 - 363
  • [22] Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Vazquez Gomez, Lazaro Aurelio
    Hidalgo Mesa, Carlos
    Broche Perez, Yunier
    Valdes Morales, Yanet
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (05): : 825 - 833
  • [23] A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
    Jaber, Amer
    Bozzato, Gian B.
    Vedrine, Lionel
    Prais, Wes A.
    Berube, Julie
    Laurent, Philippe E.
    BMC NEUROLOGY, 2008, 8 (1)
  • [24] A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
    Amer Jaber
    Gian B Bozzato
    Lionel Vedrine
    Wes A Prais
    Julie Berube
    Philippe E Laurent
    BMC Neurology, 8
  • [25] Combination therapy of interferon beta-1a with alefacept for active relapsing multiple sclerosis patients
    Weinstock-Guttman, B
    Ramanathan, M
    Zivadinov, R
    Munschauer, FE
    MULTIPLE SCLEROSIS, 2005, 11 : S79 - S79
  • [26] Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
    Rudick, RA
    Goodkin, DE
    Jacobs, LD
    Cookfair, DL
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Granger, CV
    Simon, JH
    Alam, JJ
    Simonian, NA
    Campion, MK
    Bartoszak, DM
    Bourdette, DN
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Priore, RL
    Pullicino, PM
    Scherokman, BJ
    Weistock-Guttman, B
    Whitham, RH
    NEUROLOGY, 2001, 57 (12) : S25 - S30
  • [27] Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
    Kappos, L.
    Wiendl, H.
    Selmaj, K.
    Arnold, D. L.
    Havrdova, E.
    Boyko, A.
    Kaufman, M.
    Rose, J.
    Greenberg, S.
    Sweetser, M.
    Riester, K.
    O'Neill, G.
    Elkins, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (15): : 1418 - 1428
  • [28] Evaluation of the risk of malignancies in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Alteri, E.
    Kornmann, G.
    Moraga, M. Stam
    Casset-Semanaz, F.
    Miret, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S204 - S205
  • [29] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [30] COMPARISON OF MEDICATION ADHERENCE TO INTERFERON BETA-1B AND INTERFERON BETA-1A SUBCUTANEOUS IN MULTIPLE SCLEROSIS PATIENTS
    Meletiche, D. M.
    Kozma, C.
    Dickson, M.
    VALUE IN HEALTH, 2009, 12 (03) : A194 - A194